Literature DB >> 23346798

PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration--a possible link to the development of the disease.

Anna Machalińska1, Krzysztof Safranow, Katarzyna Mozolewska-Piotrowska, Violetta Dziedziejko, Danuta Karczewicz.   

Abstract

PURPOSE: The aim of the study is to explore the interaction between stimulators and inhibitors of angiogenesis by measuring pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) plasma levels in patients with the wet and dry forms of age-related macular degeneration (AMD).
MATERIAL AND METHODS: Forty-six subjects with the wet form, 31 with the dry form of AMD as well as 47 non-AMD healthy controls were enrolled in the study. Plasma concentrations of VEGF and PEDF were measured using ELISA test.
RESULTS: A significant decrease in the PEDF plasma level in patients with the dry form of AMD was found. Multivariate analyses of patients and controls adjusted for age, sex, smoking, and concomitant vascular diseases as independent variables revealed that the dry form of AMD was the only independent factor associated with lower plasma PEDF levels (beta = -0.34; p = 0.026). On the contrary, in the wet AMD group, a strong positive correlation between VEGF and PEDF concentrations was observed (Rs = +0.63; p = 0.002), and significantly higher PEDF and VEGF plasma levels in patients with bilateral manifestations of the disease were also found.
CONCLUSIONS: These findings suggest that different manifestations of AMD, i.e. the dry and wet forms, may be associated with various altered concentrations of counterbalancing stimulators and inhibitors of the angiogenesis process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23346798

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  11 in total

1.  Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology.

Authors:  Elisabeth Obert; Randy Strauss; Carlene Brandon; Christina Grek; Gautam Ghatnekar; Robert Gourdie; Bärbel Rohrer
Journal:  J Mol Med (Berl)       Date:  2017-01-28       Impact factor: 4.599

2.  PEDF expression affects the oxidative and inflammatory state of choroidal endothelial cells.

Authors:  Mitra Farnoodian; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-10       Impact factor: 4.249

3.  Ablation of the riboflavin-binding protein retbindin reduces flavin levels and leads to progressive and dose-dependent degeneration of rods and cones.

Authors:  Ryan A Kelley; Muayyad R Al-Ubaidi; Tirthankar Sinha; Ayse M Genc; Mustafa S Makia; Larissa Ikelle; Muna I Naash
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

Review 4.  Negative regulators of angiogenesis: important targets for treatment of exudative AMD.

Authors:  Mitra Farnoodian; Shoujian Wang; Joel Dietz; Robert W Nickells; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2017-07-05       Impact factor: 6.124

Review 5.  Future therapies of wet age-related macular degeneration.

Authors:  Makoto Ishikawa; Daisuke Jin; Yu Sawada; Sanae Abe; Takeshi Yoshitomi
Journal:  J Ophthalmol       Date:  2015-02-24       Impact factor: 1.909

6.  Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.

Authors:  Mitra Farnoodian; James B Kinter; Saeed Yadranji Aghdam; Ismail Zaitoun; Christine M Sorenson; Nader Sheibani
Journal:  Physiol Rep       Date:  2015-01-19

7.  Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.

Authors:  Zygoula Ioanna; Schori Christian; Grimm Christian; Barthelmes Daniel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-25       Impact factor: 3.117

Review 8.  Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease.

Authors:  Alessandra Micera; Bijorn Omar Balzamino; Antonio Di Zazzo; Lucia Dinice; Stefano Bonini; Marco Coassin
Journal:  Front Pharmacol       Date:  2021-01-18       Impact factor: 5.810

9.  Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.

Authors:  Murray H Brilliant; Kamyar Vaziri; Thomas B Connor; Stephen G Schwartz; Joseph J Carroll; Catherine A McCarty; Steven J Schrodi; Scott J Hebbring; Krishna S Kishor; Harry W Flynn; Andrew A Moshfeghi; Darius M Moshfeghi; M Elizabeth Fini; Brian S McKay
Journal:  Am J Med       Date:  2015-10-30       Impact factor: 4.965

10.  Laminin modification subretinal bio-scaffold remodels retinal pigment epithelium-driven microenvironment in vitro and in vivo.

Authors:  Chi-Hsien Peng; Jen-Hua Chuang; Mong-Lien Wang; Yong-Yu Jhan; Ke-Hung Chien; Yu-Chien Chung; Kuo-Hsuan Hung; Chia-Ching Chang; Chao-Kuei Lee; Wei-Lien Tseng; De-Kuang Hwang; Chia-Hsien Hsu; Tai-Chi Lin; Shih-Hwa Chiou; Shih-Jen Chen
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.